Andrew Hirsch - President & CEO, Director at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
CCCC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Hirsch since 11 Feb 2025

Holdings reported by Andrew Hirsch for C4 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 423,145 $1,345,601 $3.18 15 Feb 2025 Direct
Performance Restricted Stock Units 35,000 $194,600 $5.56 07 Nov 2024 Direct Common Stock
Stock Option (Right to Buy) 335,300 14 Feb 2025 Direct Common Stock

Transactions reported by Andrew Hirsch for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.